Peer reviewed
Metformin as a Tool to Target Aging (TAME concept article)
Nir Barzilai and colleagues outline the scientific rationale and design of the TAME trial, arguing that metformin's AMPK-activating, insulin-sensitizing effects make it a candidate to target aging biology.
Cell Metabolism / ElsevierPublished 2016-09-13Accessed 2026-07-01
Registry record
Source metadata
- Publisher
- Cell Metabolism / Elsevier
- Source type
- Peer reviewed
- Registry ID
barzilai-tame-concept-2016
Interpretation boundary
What this record can and cannot establish
Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.